Lawyers in China

Aaron Lee

Partner

Hylands Law Firm

Abe Zhao

Senior Tax Consulting Director

FenXun Partners

Adam (Qi) Li

Partner

JunHe

Adam Long

Partner

Topcom China Law Offices

Adrian Emch

Consultant

Hylands Law Firm

Ai FENG

Partner

JunHe

Ai Tong

Ai Tong is a corporate lawyer based in Shanghai. She has about 15 years' experience in China-related corporate and regulatory matters, Ai has considerable experience advising clients in cross-border merger and acquisition transactions, foreign direct investments, joint ventures and general corporate matters. Specifically, Ai has extensive experience in dealing with China's financial and FinTech related regulations. Ai's experience includes advising clients on both transactions and regulatory matters involving foreign investments in China by foreign financial institutions, including but not limited to insurers(reinsurers), insurance intermediaries, banks, fund/asset managers, and on regulatory aspects of distribution and resale networks for financial products in China. Ai is also a core team member in the firm's insurance, FinTech and asset management practices in China.

Norton Rose Fulbright

Aidong Lou

Senior Partner

Kangda Law Firm

Aihua Xiao

Partner

Tian Yuan Law Firm

Aimin Zhang

Partner

Dehehantong Law Offices

Alan Bao

Partner

White & Case

Alan GUO

Partner

Hylands Law Firm

Alan Zhou

Alan Zhou's practice is focused in the areas of mergers & acquisitions, private equity/venture capital, regulatory compliance, and general corporate. Mr. Zhou has a particularly strong background in pharmaceutical and healthcare industrial sectors. Mr. Zhou has represented many multinational corporations, reputable Chinese state owned and private corporations, and private equity/venture capital funds. He has routinely represented such multinational corporations as Sanofi, Schlumberger, Siemens, Boehringer Ingelheim, Novartis, Aon, Bureau Veritas, Catalent, Terumo, Tosoh, Barclays, Societe Generale Bank, Samsung and SK Telecom. Mr. Zhou has not only worked for reputable Chinese private companies such as Focus Media, VIPShop, Acorn International, Hisoar Pharmaceutical, Tianyuan Biopharm, and GeneScience Pharma, he has also advised PRC state owned companies such as Shanghai Dasheng, Shanghai Industrial and Shanghai Airport Authority. ��In the area of PE/VC, Mr. Zhou has acted for CBRE Investors, Colony Capital, Navis Capital, Lightspeed Ventures, Qiming Ventures, DT Capital, NEA, New Alliance Capital, Warden International, WINS and other international and local PE/VC funds.

Global Law Office

Aldo Boni De Nobili

Counsel

Hogan Lovells International LLP

Alex Huang

Partner

Llinks Law Offices

Alex Liu

Alex Liu focuses on mergers and acquisitions, private equity investment & financing, and capital markets, with established expertise on takeover and restructuring of public companies, state-owned assets related transactions, cross-border M&A and red-chip restructuring. In the field of merger and acquisitions, Alex has been involved in many representative deals, which include: Takeover of control, such as, Infore Group’s over RMB 8.88 billion takeover of KUCA (603816.SH); Broadex’s (300548.SZ) takeover by YOFC (601869.SH; 06869.HK); Orient Zirconic’s (002167.SZ) takeover by LB Group (002601.SZ); Meiya Pico’s (300188.SZ) takeover by SDIC; Sichuan Shuangma’s (000935.SZ) takeover by IDG Capital; and Cangzhou Dahua’s (600230.SH) sale by a central SOE. Restructuring by public companies, such as, Zoomlion’s (000157.SZ; 01157.HK) carve-out by way of RoadRover’s (002813.SZ) backdoor listing; Synermore Biologics’ sale to NUCIEN (688189.SH); NuClover’s sale to Jieqiang Equipment (300875.SZ); affiliates’ restructuring by SOE YNHC (001896.SZ); and merger of Huabei Expressway (000916) by China Merchants Highway. Cross-border M&A transactions, such as, over RMB 3.3 billion strategic investment into CGN’s Brazilian subsidiary; over RMB 18.47 billion takeover of Israel’s ADAMA by Sanonda (000553.SZ); merger integration of Xiamen Port involving three A-shares and two HK listed companies; combination of CR Pharmaceutical and Beijing Pharmaceutical involving four A-shares companies; acquisition of Tianjin Port (600717.SH) by Tianjin Port Development (00382.HK) through shares exchange; RTO of HanKore Environment (U9E.SGX) by Everbright International (00257.HK); VSA injecting properties by CR Land (01109.HK); sale of TNUVA to Bright Food by APAX Fund; and acquisition of skiing resorts in Yabuli by Melco. Red-chip or VIE restructuring, Alex’s representative clients include Xiyun, Douyu, EASOU Technology, Bangcle, Chunyu Yisheng, Baixing.com, and Baofeng Group etc. In the field of PE investment and financing, Alex has represented numerous RMB or USD funds such as China Merchants Capital, CDB Capital, CIIF, Hony Capital, Goldstone, and Jinrong Street Capital etc., in investments ranging from technology, healthcare to energy sectors. In capital markets, Alex has advised on the listings or additional issues on the stock exchanges in Shanghai, Shenzhen, Beijing, Hong Kong or US, including the IPO of China Resources Microelectronics (688396.SH) on SSE STAR, the first case in Chinese capital markets of an offshore red-chip company; Douyu.com (DOYU) and VisionChina (VISN)’s Nasdaq listing; Tong Ji Tang’s NYSE listing; Dynasty (00828), Huaying Highway (01823), Hongba Digital (00802) and Sanlin Global (019020)’s HKSE listing; Vanke’s B to H share conversion; and the delisting of Zhengzhou Gas, etc.

Global Law Office

Alexander Gong

Partner

Baker McKenzie FenXun

Alexander Gong

Partner

FenXun Partners

Alexandra Yang

Partner

Fangda Partners

Allan Chen

Partner

Fangda Partners

Allen Fu

Partner

Fangda Partners

Allen Xu

DLA Piper

Alma Díaz

Associate

Greenberg Traurig

Alvin Sin

Alvin is a Partner in the Dispute Resolution department of Appleby’s Shanghai office, and a Legal Manager of Appleby’s Hong Kong office.

Appleby